(Q70228278)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Orally administered bovine colostral anti-cholera toxin antibodies: results of two clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

R E McClead

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

T Butler

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

G H Rabbani

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 December 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

811-816

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

A Randomized, Controlled Trial of the Toxin-Blocking Effects of B Subunit in Family Members of Patients with Cholera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

Protection against cholera in breast-fed children by antibodies in breast milk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

A QUANTITATIVE STUDY OF THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND PURIFIED HOMOLOGOUS ANTIBODY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

The Titration of Cholera Toxin and Antitoxin in the Rabbit Ileal Loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

Enterotoxigenic Escherichia coli Isolated from Patients with Severe Cholera-like Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

Passive oral immunization with bovine immunoglobulins: enterpathogenic Escherichia coli from infants and bovine anti-E. coli lactoserum assayed in the rabbit ileal loop model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

Lyophilized bovine colostrum in the treatment of prolonged infantile diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

Reduction of fluid-loss in cholera by nicotinic acid: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

7 January 2021

Binding of intraluminal toxin in cholera: trial of GM1 ganglioside charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

7 January 2021

Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

7 January 2021

Proteolysis of Bovine Immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

7 January 2021

Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980026-3

7 January 2021

10.1016/S0002-9343(88)80026-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3057900%20AND%20SRC:MED&resulttype=core&format=json